A case of sternal osteomyelitis during treatment with everolimus for recurrent breast cancer
Abstract Background Everolimus is a mechanistic-target-of-rapamycin (mTOR) inhibitor bearing a potent antitumor effect against hormone receptor-positive breast cancer. Here, we report the case of a patient with recurrent breast cancer who developed osteomyelitis during the treatment with everolimus...
Saved in:
| Main Authors: | Kaori Abe, Masafumi Shimoda, Tetsuhiro Yoshinami, Yoshiaki Sota, Tomohiro Miyake, Tomonori Tanei, Naofumi Kagara, Yasuto Naoi, Kenzo Shimazu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Japan Surgical Society
2022-01-01
|
| Series: | Surgical Case Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40792-022-01376-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Beyond the rare: a case of pseudomyogenic hemangioendothelioma treated sequentially with everolimus, denosumab, and pazopanib
by: Douglas Dias e Silva, et al.
Published: (2024-12-01) -
Primary sternal osteomyelitis in an immunocompetent adolescent
by: Fadwa Jaheddine, et al.
Published: (2025-06-01) -
Hypercalcemia affected in metastatic breast cancer patients without bone metastasis: report of three cases
by: Sakina Hashizume, et al.
Published: (2022-11-01) -
Forms of sternal reconstruction in oncology
by: A. A. Kurilchik, et al.
Published: (2021-08-01) -
Novel mesh suture may resist bone cutting seen with wire-based sternal closuresCentral MessagePerspective
by: Sandeep N. Bharadwaj, MD, et al.
Published: (2023-08-01)